ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price shot up 9.3% during mid-day trading on Friday . The company traded as high as $0.45 and last traded at $0.45. 285,512 shares changed hands during trading, an increase of 1,305% from the average session volume of 20,327 shares. The stock had previously closed at $0.41.
ImmunoPrecise Antibodies Stock Performance
The company’s 50 day moving average is $0.42 and its 200-day moving average is $0.65.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How to Use the MarketBeat Excel Dividend Calculator
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
